BDBM222706 6-{[(1r)-1- cyclobutylethyl]amino}-8- (1,4-dimethylpiperidin-2- yl)-7-[(trans-4- methylcyclohexyl)methyl]- 7h-purine-2-carboxylic acid::US9540377, 10.33

SMILES CC1CCN(C)C(c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2C[C@H]2CC[C@H](C)CC2)C1

InChI Key InChIKey=CJXHLCPTWKUUKT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 222706   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 222706BDBM222706(US9540377, 10.33 | 6-{[(1r)-1- cyclobutylethyl]ami...)
Affinity DataIC50: 17.7nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent